CI-994 - ≥98%, high purity , Histone deacetylase inhibitor, CAS No.112522-64-2, Histone deacetylase inhibitor

Item Number

C126432

• Synonyms: Tacedinaline | 112522-64-2 | ci-994 | 4-acetamido-N-(2-aminophenyl)benzamide | Acetyldinaline | CI 994 | 4-acetylamino-N-(2'-aminophenyl)benzamide | CI994 (Tacedinaline) | Tacedinalina | N-acetyldinaline | Goe 5549 | Goe-5549 | PD-123654 | PD 123654 | 4-(Acetylamino)-N-(2-aminopheny
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Description: IC50 Value: 0.57 uM (For HDAC1,MTT assay) CI-994 (N-acetyldinaline) is a novel oral compound with a wide spectrum of antitumor activity in preclinical models, in vitro and in vivo. The mechanism of action may involve inhibition of histone dea
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Histone deacetylase inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM and causes G1 cell cycle arrest.
An HDAC1, HDAC3, HDAC6, and HDAC8 inhibitor